LP429469-2BrexpiprazoleActive

Description

LP429469-2 Brexpiprazole
Brexpiprazole is known as 'atypical' antipsychotic drug approved by the FDA in July 2015 for treatment of schizophrenia and adjunctive therapy for major depressive disorder. [PMID:PMC6007711] Source: Regenstrief LOINC

Basic Part Properties

Name: Brexpiprazole
Type: Component
Created On: 2021-09-03
Construct for LOINC Short Name: Brexpiprazole

Related Codes

Code System	Code	Code Text	Code Version
https://www.ebi.ac.uk/chebi	CHEBI:134716	brexpiprazole	ChEBI Release 203
http://pubchem.ncbi.nlm.nih.gov	11978813	Brexpiprazole

LOINC FHIR^® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP429469-2

Language Variants Get Info

zh-CNChinese (China): 依匹哌唑
Synonyms: OPC-34712;CAS 913611-97-9;Rexulti;布瑞哌唑
nl-NLDutch (Netherlands): brexpiprazol
it-ITItalian (Italy): Brexpiprazolo
es-ESSpanish (Spain): Brexpiprazol

LOINC Copyright

Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2022, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.